Diasome Pharmaceuticals Company
Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals was founded in 2004 and is based in Conshohocken, Pennsylvania.
Industry:
PharmTech
Headquarters:
Cleveland, Ohio, United States
Zip:
1-10
Founded Date:
2004-01-01
Employees Number:
1-10
Acquisitions Number:
6
Investors Number:
82994379
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
info@diasome.com
Register and Claim Ownership